Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other financing activities (2016 - 2018)

Assembly Biosciences has reported Other financing activities over the past 4 years, most recently at -$543780.0 for Q3 2018.

  • Quarterly results put Other financing activities at -$543780.0 for Q3 2018, down 451.84% from a year ago — trailing twelve months through Sep 2018 was -$524726.0 (down 138.03% YoY), and the annual figure for FY2017 was -$84192.0, down 44.64%.
  • Other financing activities for Q3 2018 was -$543780.0 at Assembly Biosciences, down from $18857.0 in the prior quarter.
  • Over the last five years, Other financing activities for ASMB hit a ceiling of $86231.0 in Q4 2017 and a floor of -$543780.0 in Q3 2018.
  • Median Other financing activities over the past 4 years was -$27032.0 (2015), compared with a mean of -$63494.7.
  • Biggest five-year swings in Other financing activities: skyrocketed 293.32% in 2017 and later crashed 724.97% in 2018.
  • Assembly Biosciences' Other financing activities stood at -$27032.0 in 2015, then plummeted by 85.05% to -$50022.0 in 2016, then surged by 272.39% to $86231.0 in 2017, then plummeted by 730.61% to -$543780.0 in 2018.
  • The last three reported values for Other financing activities were -$543780.0 (Q3 2018), $18857.0 (Q2 2018), and -$86034.0 (Q1 2018) per Business Quant data.